Literature DB >> 31448449

Prenatal paracetamol exposure and neurodevelopmental outcomes in preschool-aged children.

Johanne N Trønnes1, Mollie Wood1,2, Angela Lupattelli1, Eivind Ystrom1,3,4, Hedvig Nordeng1,5.   

Abstract

BACKGROUND: Recent studies have suggested an association between prenatal paracetamol exposure and adverse neurodevelopmental outcomes in children. However, these findings may be confounded by unmeasured factors related to maternal use of paracetamol and child outcomes.
OBJECTIVE: To examine the association between duration and timing of prenatal paracetamol exposure on parent-reported communication skills, behaviour, and temperament in preschool-aged children, with focus on the role of unmeasured confounding.
METHODS: We used data from the Norwegian Mother and Child Cohort Study. Linear and generalised linear models with inverse probability weights and robust standard errors were used to quantify the association between prenatal paracetamol exposure and continuous and categorical outcomes.
RESULTS: Of the 32 934 children included in our study, 8374 (25.4%), 4961 (15.1%), and 1791 (5.4%) were prenatally exposed to paracetamol in one, two, and three trimesters, respectively. Children exposed to paracetamol in two trimesters scored lower on shyness compared with unexposed children (β -0.62, 95% confidence interval [CI] -1.05, -0.19). Children exposed to paracetamol in three trimesters had a moderate increased risk of internalising behaviour problems (relative risk (RR) 1.36, 95% CI 1.02, 1.80) and borderline externalising behaviour problems (RR 1.22, 95% CI 0.93, 1.60) compared with unexposed children. Children exposed to paracetamol in 2nd/3rd trimester scored lower on shyness (β -0.32, 95% CI -0.66, 0.02) compared with unexposed children. Sensitivity analyses indicated that unmeasured confounders play an important role and may potentially bias the effect estimates away from the null.
CONCLUSIONS: Timing of exposure and short-term use of paracetamol during pregnancy do not seem to pose any substantial risk of the outcomes examined. Although we found an association between paracetamol use in multiple trimesters and lower shyness and greater internalising behaviour in preschool-aged children, we cannot rule out chance or unmeasured confounding as possible explanations for these findings.
© 2019 The Authors. Paediatric and Perinatal Epidemiology Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MoBa; child neurodevelopment; paracetamol; pregnancy

Mesh:

Substances:

Year:  2019        PMID: 31448449     DOI: 10.1111/ppe.12568

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  5 in total

1.  Maternal persistent marijuana use and cigarette smoking are independently associated with shorter gestational age.

Authors:  Nobutoshi Nawa; Henri M Garrison-Desany; Yoona Kim; Yuelong Ji; Xiumei Hong; Guoying Wang; Colleen Pearson; Barry S Zuckerman; Xiaobin Wang; Pamela J Surkan
Journal:  Paediatr Perinat Epidemiol       Date:  2020-06-30       Impact factor: 3.980

2.  Associations between prenatal acetaminophen exposure and child neurodevelopment: Truth, bias, or a bit of both?

Authors:  Mollie E Wood
Journal:  Paediatr Perinat Epidemiol       Date:  2020-02-22       Impact factor: 3.980

Review 3.  Paracetamol (Acetaminophen) and the Developing Brain.

Authors:  Christoph Bührer; Stefanie Endesfelder; Till Scheuer; Thomas Schmitz
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

4.  Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study.

Authors:  Jennifer M Lye; Julia A Knight; Jasleen Arneja; Ryan A Seeto; Jody Wong; Nadya Adel Khani; Jennifer D Brooks; Robert D Levitan; Stephen G Matthews; Stephen J Lye; Rayjean J Hung
Journal:  Pediatr Res       Date:  2022-07-07       Impact factor: 3.953

5.  Maternal use of acetaminophen during pregnancy and neurobehavioral problems in offspring at 3 years: A prospective cohort study.

Authors:  Kristin K Sznajder; Douglas M Teti; Kristen H Kjerulff
Journal:  PLoS One       Date:  2022-09-28       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.